---

---

Practice Areas: Whistleblower Claims

Additional Information: Linda J. Stengle is the Chief Executive Officer and President of Stengle Law. Prior to leading this firm, Stengle’s legal practice was dedicated to pursuing qui tam recoveries on behalf of whistleblowers reporting government false claims; tax underpayments; and securities violations. She has worked on cases that received some of the highest awards in the history of these programs, including the $2.3 billion Pfizer off-label marketing settlement and the $420 million Cephalon settlement.

She is one of the few attorneys who successfully represented IRS whistleblowers in US Tax Court, obtaining multi-million dollar rewards for her clients from the IRS. With low initial investment, Stengle has been able to obtain large awards for her clients when other qui tam attorneys have failed.

Stengle is a Certified Fraud Specialist and on the faculty of the Association of Certified Fraud Specialists. She is a thought leader in the area of decentralized anti-fraud enforcement and systems change. The Delaware Journal of Corporate Law published her article Rewarding Integrity: The Struggle to Protect Decentralized Law Enforcement through the Public Disclosure Bar of the False Claims Act. In addition to publishing several articles and 2 books, Stengle has spoken on panels for the Association of Certified Fraud Specialists and Taxpayers Against Fraud.

Stengle is licensed in Pennsylvania, New York, New Jersey and the District of Columbia. She is admitted to practice before the United States Tax Court; the United States Court of Federal Claims; the United States District Court for the Eastern District of Pennsylvania; the United States District Court for the District of New Jersey; as well as the Eastern and Southern Districts of New York.